Related Experiment Video

Updated: Jul 14, 2026

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
06:22

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

Published on: September 17, 2015

Phospholamban: a crucial regulator of cardiac contractility

David H MacLennan1, Evangelia G Kranias

  • 1Banting and Best Department of Medical Research, University of Toronto, Charles H. Best Institute, 112 College Street, Toronto, Ontario M5G 1L6, Canada. david.maclennan@utoronto.ca

Nature Reviews. Molecular Cell Biology
|July 3, 2003
PubMed

Insights

Altered phospholamban activity impairs heart function, leading to dilated cardiomyopathy in both mice and humans. Even in healthy hearts, phospholamban dysfunction can cause significant cardiac issues.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Heart failure is a leading cause of death and disability.
  • Circulatory impairments in heart failure are linked to the sarcoplasmic reticulum Ca2+ pump.
  • Phospholamban regulates the Ca2+ pump, influencing cardiac contractility.

Purpose of the Study:

  • To investigate the role of phospholamban in heart failure and dilated cardiomyopathy.
  • To understand the impact of phospholamban's altered activity on cardiac function.

Main Methods:

  • Studied the interaction between phospholamban and the sarcoplasmic reticulum Ca2+ pump.
  • Examined the effects of superinhibitory or chronically inhibitory phospholamban.
  • Utilized mouse models and human genetic data (phospholamban-null genotype).

Main Results:

  • Dysfunctional phospholamban leads to diminished cardiac contractility.
  • This dysfunction induces dilated cardiomyopathy in both mice and humans.
  • In mice, phospholamban can impair an otherwise healthy heart.
  • Humans with a phospholamban-null genotype exhibit early-onset dilated cardiomyopathy.

Conclusions:

  • Phospholamban's regulatory role is critical for maintaining normal cardiac function.
  • Abnormal phospholamban activity is a key factor in the development of dilated cardiomyopathy.
  • Genetic variations in phospholamban can predispose individuals to heart conditions.

More Related Videos

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling08:29

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling

Published on: August 1, 2016

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials